gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Experimental Neoplasms in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, K; Huang, SW; Li, XQ; Li, YS; Liao, RF; Lu, ST; Wan, B; Wu, B; Wu, BL; Xu, HB | 1 |
Bussink, J; Hectors, SJ; Hoeben, FJ; Jacobs, I; Janssen, HM; Keizer, HM; Lok, J; Nicolay, K; Peters, J; Schabel, MC; Strijkers, GJ | 1 |
Darrasse, L; Gargam, N; Ginefri, JC; Poirier-Quinot, M; Raynaud, JS; Robert, P | 1 |
Cho, H; Jung, H; Kang, S; Kang, YJ; Kim, H; Song, Y | 1 |
Escher, E; Guérin, B; Jastrzebska, B; Lebel, R; Lepage, M; McIntyre, JO; Neugebauer, WA; Paquette, B; Therriault, H | 1 |
Chen, Q; Jeong, EK; Lu, ZR; Tan, M; Wu, X | 1 |
Brasch, RC; Chaopathomkul, B; Cyran, CC; Fu, Y; Raatschen, HJ; Rogut, V; Shames, DM; Wendland, MF; Yeh, BM | 1 |
Kim, JH; Kim, S; Min, BG; Moon, WK | 1 |
Baltzer, L; Brechbiel, MW; Colcher, D; Gansow, OA; Girton, ME; Knop, RH; Magerstädt, M; Naegele, M | 1 |
9 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Experimental Neoplasms
Article | Year |
---|---|
Near-infrared light-triggered theranostics for tumor-specific enhanced multimodal imaging and photothermal therapy.
Topics: Animals; Contrast Media; Female; Heterocyclic Compounds; Humans; Indocyanine Green; Infrared Rays; Liposomes; Magnetic Resonance Imaging; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Neoplasms; Neoplasms, Experimental; Organometallic Compounds; Phototherapy; Signal-To-Noise Ratio; Theranostic Nanomedicine | 2017 |
Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI.
Topics: Animals; Capillary Permeability; Contrast Media; Dendrimers; Heterocyclic Compounds; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Mice, Inbred BALB C; Neoplasms, Experimental; Organometallic Compounds; Placebos; Xanthones | 2018 |
Experimental system to detect a labeled cell monolayer in a microfluidic environment.
Topics: Animals; Cell Tracking; Contrast Media; Equipment Design; Equipment Failure Analysis; Feasibility Studies; Heterocyclic Compounds; Humans; KB Cells; Lab-On-A-Chip Devices; Magnetic Resonance Imaging; Neoplasms, Experimental; Organometallic Compounds; Staining and Labeling; Tumor Microenvironment | 2015 |
Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI.
Topics: Animals; Contrast Media; Heterocyclic Compounds; Magnetic Resonance Imaging; Mice; Multienzyme Complexes; Nanoparticles; Neoplasms, Experimental; Organometallic Compounds | 2015 |
New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imaging.
Topics: Animals; Contrast Media; Heterocyclic Compounds; Magnetic Resonance Imaging; Matrix Metalloproteinase 2; Mice; Neoplasms, Experimental; Organometallic Compounds; Solubility; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2009 |
Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Extracellular Matrix; Female; Fibronectins; Heterocyclic Compounds; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Nanostructures; Neoplasms, Experimental; Organometallic Compounds; Peptides; Tissue Distribution | 2010 |
New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues.
Topics: Animals; Breast Neoplasms; Contrast Media; Endothelium, Vascular; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Rats; Rats, Nude; Transplantation, Heterologous | 2008 |
Lesion characterization using vessel permeability map to new blood pool contrast agent calculated from dynamic magnetic resonance images.
Topics: Abscess; Animals; Capillary Permeability; Contrast Media; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Neoplasms, Experimental; Organometallic Compounds; Rabbits; Sensitivity and Specificity; Testicular Neoplasms; Tumor Cells, Cultured | 2000 |
Gd(DOTA): an alternative to Gd(DTPA) as a T1,2 relaxation agent for NMR imaging or spectroscopy.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Spectroscopy; Mice; Neoplasms, Experimental; Organometallic Compounds; Pentetic Acid; Spectrum Analysis | 1986 |